Karen A Ryall1, Jimin Shin1, Minjae Yoo1, Trista K Hinz2, Jihye Kim1, Jaewoo Kang3, Lynn E Heasley1, Aik Choon Tan4. 1. Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine. 2. Department of Craniofacial Biology, School of Dental Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 3. Department of Computer Science and Engineering, Korea University, Seoul, Korea and. 4. Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine, Department of Computer Science and Engineering, Korea University, Seoul, Korea and Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Abstract
MOTIVATION: Targeted kinase inhibitors have dramatically improved cancer treatment, but kinase dependency for an individual patient or cancer cell can be challenging to predict. Kinase dependency does not always correspond with gene expression and mutation status. High-throughput drug screens are powerful tools for determining kinase dependency, but drug polypharmacology can make results difficult to interpret. RESULTS: We developed Kinase Addiction Ranker (KAR), an algorithm that integrates high-throughput drug screening data, comprehensive kinase inhibition data and gene expression profiles to identify kinase dependency in cancer cells. We applied KAR to predict kinase dependency of 21 lung cancer cell lines and 151 leukemia patient samples using published datasets. We experimentally validated KAR predictions of FGFR and MTOR dependence in lung cancer cell line H1581, showing synergistic reduction in proliferation after combining ponatinib and AZD8055. AVAILABILITY AND IMPLEMENTATION: KAR can be downloaded as a Python function or a MATLAB script along with example inputs and outputs at: http://tanlab.ucdenver.edu/KAR/. CONTACT: aikchoon.tan@ucdenver.edu. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
MOTIVATION: Targeted kinase inhibitors have dramatically improved cancer treatment, but kinase dependency for an individual patient or cancer cell can be challenging to predict. Kinase dependency does not always correspond with gene expression and mutation status. High-throughput drug screens are powerful tools for determining kinase dependency, but drug polypharmacology can make results difficult to interpret. RESULTS: We developed Kinase Addiction Ranker (KAR), an algorithm that integrates high-throughput drug screening data, comprehensive kinase inhibition data and gene expression profiles to identify kinase dependency in cancer cells. We applied KAR to predict kinase dependency of 21 lung cancer cell lines and 151 leukemiapatient samples using published datasets. We experimentally validated KAR predictions of FGFR and MTORdependence in lung cancer cell line H1581, showing synergistic reduction in proliferation after combining ponatinib and AZD8055. AVAILABILITY AND IMPLEMENTATION: KAR can be downloaded as a Python function or a MATLAB script along with example inputs and outputs at: http://tanlab.ucdenver.edu/KAR/. CONTACT: aikchoon.tan@ucdenver.edu. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Authors: Kwang Sup So; Jin Kyung Rho; Yun Jung Choi; Seon Ye Kim; Chang Min Choi; Young Jin Chun; Jae Cheol Lee Journal: Anticancer Res Date: 2015-03 Impact factor: 2.480
Authors: Katherine R Singleton; Trista K Hinz; Emily K Kleczko; Lindsay A Marek; Jeff Kwak; Taylor Harp; Jihye Kim; Aik Choon Tan; Lynn E Heasley Journal: Cancer Res Date: 2015-09-10 Impact factor: 12.701
Authors: Patrick P Zarrinkar; Ruwanthi N Gunawardane; Merryl D Cramer; Michael F Gardner; Daniel Brigham; Barbara Belli; Mazen W Karaman; Keith W Pratz; Gabriel Pallares; Qi Chao; Kelly G Sprankle; Hitesh K Patel; Mark Levis; Robert C Armstrong; Joyce James; Shripad S Bhagwat Journal: Blood Date: 2009-08-04 Impact factor: 22.113
Authors: Jeffrey W Tyner; Wayne F Yang; Armand Bankhead; Guang Fan; Luke B Fletcher; Jade Bryant; Jason M Glover; Bill H Chang; Stephen E Spurgeon; William H Fleming; Tibor Kovacsovics; Jason R Gotlib; Stephen T Oh; Michael W Deininger; Christian Michel Zwaan; Monique L Den Boer; Marry M van den Heuvel-Eibrink; Thomas O'Hare; Brian J Druker; Marc M Loriaux Journal: Cancer Res Date: 2012-10-18 Impact factor: 12.701
Authors: Wanjuan Yang; Jorge Soares; Patricia Greninger; Elena J Edelman; Howard Lightfoot; Simon Forbes; Nidhi Bindal; Dave Beare; James A Smith; I Richard Thompson; Sridhar Ramaswamy; P Andrew Futreal; Daniel A Haber; Michael R Stratton; Cyril Benes; Ultan McDermott; Mathew J Garnett Journal: Nucleic Acids Res Date: 2012-11-23 Impact factor: 16.971
Authors: Karen A Ryall; Jihye Kim; Peter J Klauck; Jimin Shin; Minjae Yoo; Anastasia Ionkina; Todd M Pitts; John J Tentler; Jennifer R Diamond; S Gail Eckhardt; Lynn E Heasley; Jaewoo Kang; Aik Choon Tan Journal: BMC Genomics Date: 2015-12-09 Impact factor: 3.969
Authors: Nadia Arang; Heather S Kain; Elizabeth K Glennon; Thomas Bello; Denali R Dudgeon; Emily N F Walter; Taranjit S Gujral; Alexis Kaushansky Journal: Nat Commun Date: 2017-11-01 Impact factor: 14.919
Authors: Hong Sheng Cheng; Charlie Marvalim; Pengcheng Zhu; Cheng Lui Daniel Law; Zhi Yan Jeremy Low; Yuk Kien Chong; Beng Ti Ang; Carol Tang; Nguan Soon Tan Journal: Theranostics Date: 2021-03-05 Impact factor: 11.556
Authors: David H Drewry; Carrow I Wells; David M Andrews; Richard Angell; Hassan Al-Ali; Alison D Axtman; Stephen J Capuzzi; Jonathan M Elkins; Peter Ettmayer; Mathias Frederiksen; Opher Gileadi; Nathanael Gray; Alice Hooper; Stefan Knapp; Stefan Laufer; Ulrich Luecking; Michael Michaelides; Susanne Müller; Eugene Muratov; R Aldrin Denny; Kumar S Saikatendu; Daniel K Treiber; William J Zuercher; Timothy M Willson Journal: PLoS One Date: 2017-08-02 Impact factor: 3.240